Loading ...

Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies

(

)

ITN Protocol #:

ITN019AD

Branded Name:

ClinicalTrials.Gov ID:

Treatment Protocol #:

Therapeutic Area:

Allergy & Asthma

Current Status:

Complete

ITN Website Clinical Trial Recruiting Site Document Portal Location Study on ITN TrialShare

Summary:

Allergen immunotherapy Co-administered with Omalizumab

Clinical Operations Manager

NIAID Project Manager

Study Personnel:

Protocol Chair

Thomas Casale, MD casalej@creighton.edu

Work:

(402)280-4403

Protocol Chair

Don Whitehouse dwhitehouse@immunetolerance.org

Work:

415-353-4426

Protocol Chair

Joy Laurienzo JLaurienzo@niaid.nih.gov

Work:

301-451-4415

Admin Links

Shortcuts

ITN Documents

Links